Drug Profile


Alternative Names: Adifax; D-fenfluramine; Dextrofenfluramine; Dipondal; IP 001; Isomeride; Obedial; Redux; S 5614

Latest Information Update: 27 Apr 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Servier
  • Class Anorectics; Small molecules
  • Mechanism of Action Serotonin release stimulants; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Obesity

Most Recent Events

  • 27 Apr 2000 Fenfluramine/dexfenfluramine has been withdrawn in Europe
  • 28 Sep 1998 Results of 3 studies looking at the evidence linking anorectics with valvular heart disease have been added to the Adverse Events section ,,,
  • 05 Jun 1998 Launched for Obesity in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top